News Sentiment

DMRA sentiment intelligence

Damora Therapeutics, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 39 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 31.48 Week of 17 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 30

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+10.3% over one week, +48.3% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

H.C. Wainwright reiterates Buy on Damora Therapeutics stock

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction 10.3% Price confirming higher
Trend fit Trend inactive 48.3% over four weeks
Fair value 112.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 32
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 30
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Stock Titan 6
MarketBeat 4
MT Newswires 4
simplywall.st 3
TradingView 3
Investing.com 2
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 11
Analyst action 3
Guidance 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 39